Top 25 Spotlight – VitaPulse Technologies

Transforming Smartwatches into Digital Guardians

Sudden cardiac arrest is one of the most time-critical medical emergencies in modern healthcare. In Canada alone, an estimated 60,000 out-of-hospital cardiac arrests occur every single year—equivalent to one event every nine minutes. Because blood stops circulating to the brain and vital organs instantly, irreversible brain damage begins in as little as five minutes. Tragically, nine out of ten Canadians who experience a cardiac arrest outside a hospital don’t survive, largely because the overwhelming majority of these events happen completely unwitnessed.

Without a bystander nearby to recognize the collapse, call 9-1-1, and initiate CPR or fetch an automated external defibrillator (AED), help simply arrives too late.

At the same time, hundreds of millions of people around the world now wear smartwatches on their wrists every day. These devices continuously track heart rates, blood flow, and movement—yet they’re primarily used for counting daily steps, monitoring sleep, and tracking workouts.

Reimagining the purpose of everyday hardware, VitaPulse Technologies is transforming these ubiquitous wrist sensors into proactive digital lifelines. Spun out of clinical research at UBC, the Vancouver startup is developing a software intelligence layer that enables standard consumer wearables to recognize meaningful changes in a person’s physiology.  

Its first application focuses on detecting acute deterioration and sudden loss-of-pulse events in real time. In this setting, a smartwatch can act as an artificial bystander—recognizing a collapse and automatically initiating an emergency alert with location information when the wearer may be unable to call for help.

But emergency detection is only the starting point. VitaPulse’s broader vision is to move wearable health monitoring from passive measurement to prediction and prevention. By analyzing physiological patterns over time, the platform is being developed to identify emerging signs of cardiac, respiratory, and other forms of deterioration before they become life-threatening.

The long-term objective is a wearable system that not only responds when a crisis occurs, but helps individuals, caregivers, and healthcare providers intervene earlier—turning smartwatches from fitness accessories into continuous, preventative health infrastructure.

From Lab to Wrist

What They’ve Done: VitaPulse has overcome the biggest hurdle in digital health AI: acquiring real clinical data. While competitors rely on simulations, VitaPulse assembled the world’s first wearable dataset of real cardiac arrest and acute physiological deterioration events. Spanning 15,000+ hours of physiological signals, this proprietary dataset provides an algorithm training ground that is nearly impossible for competitors to replicate.

That foundation has already driven key commercial milestones. VitaPulse completed a paid technology development project with a top five global smartwatch manufacturer, proving its loss-of-pulse detection system can run on mass-market hardware. Alongside licensing core UBC technology and building its VitaDash monitoring platform, the startup has secured over $1 million in non-dilutive support and initiated regulatory planning for medical-device software commercialization.

Why NVBC: This year’s New Ventures BC Competition, presented by Innovate BC, has challenged the team to sharpen their commercial playbook alongside their core science. The program pushed the founders to map how VitaPulse integrates into real-world healthcare workflows, regulatory frameworks, and emergency systems, while connecting them with key mentors, enterprise partners, and clinical leaders across BC’s life sciences network.

Up Next: The immediate focus centres on securing key regulatory milestones for commercial wearable integration. At the same time, VitaPulse is partnering with personal emergency response providers and outpatient cardiac clinics to roll out targeted pilot deployments for high-risk cardiac patients.

Building a Data Moat Competitors Can’t Touch

The VitaPulse team quickly learned a critical lesson for technical founders: a breakthrough algorithm is only half the battle. In healthcare, brilliant code can’t save lives if it fails to navigate complex regulatory approvals, reimbursement models, and clinical workflows.

Healthcare adoption demands proven clinical safety and real-world utility. By engaging clinicians and emergency responders early, the founders realized that frontline feedback is just as vital as sensor data.

This customer-first approach underscored their core competitive advantage: their proprietary dataset. In healthcare AI, data availability is the ultimate barrier to entry. Because VitaPulse built its data pipeline directly through clinical research, they hold the real-world cardiac signals needed to deploy a scientifically validated product—solving a life-threatening problem that competitors lack the data to address.